News | 12 February 2013
CORAL GABLES, FL ? February 11, 2013 -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX), a specialty pharmaceutical company focused on the development and commercialization of novel prescription drugs targeting rare (orphan) neurological ...
Click on the link to read the full article at PharmaLive (press release) (subscription)
(This link will open in a new window)